

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 7.27007946 |
| 2 | keratinocyte development (GO:0003334) | 6.28616909 |
| 3 | phospholipid homeostasis (GO:0055091) | 5.45877301 |
| 4 | platelet dense granule organization (GO:0060155) | 5.21972583 |
| 5 | L-serine transport (GO:0015825) | 4.62359535 |
| 6 | phospholipid efflux (GO:0033700) | 4.53686305 |
| 7 | protein localization to cilium (GO:0061512) | 4.24166973 |
| 8 | reverse cholesterol transport (GO:0043691) | 4.23668586 |
| 9 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.99875278 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.91161763 |
| 11 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.83085514 |
| 12 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.82156453 |
| 13 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.77738708 |
| 14 | serine transport (GO:0032329) | 3.75632266 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.74968135 |
| 16 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.66662217 |
| 17 | plasma lipoprotein particle assembly (GO:0034377) | 3.66548142 |
| 18 | intraciliary transport (GO:0042073) | 3.62916896 |
| 19 | peptidyl-cysteine modification (GO:0018198) | 3.62365926 |
| 20 | response to lipoprotein particle (GO:0055094) | 3.61150461 |
| 21 | neural tube formation (GO:0001841) | 3.46296479 |
| 22 | synaptic vesicle maturation (GO:0016188) | 3.45027226 |
| 23 | regulation of cardioblast differentiation (GO:0051890) | 3.41460147 |
| 24 | vocalization behavior (GO:0071625) | 3.41261573 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 3.40241241 |
| 26 | cell communication by electrical coupling (GO:0010644) | 3.38883582 |
| 27 | cellular potassium ion homeostasis (GO:0030007) | 3.30072415 |
| 28 | anatomical structure regression (GO:0060033) | 3.29046944 |
| 29 | glutamate secretion (GO:0014047) | 3.28770483 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.27705391 |
| 31 | sodium ion export (GO:0071436) | 3.26436239 |
| 32 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.24818087 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.19369008 |
| 34 | hindbrain development (GO:0030902) | 3.18798477 |
| 35 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.18502737 |
| 36 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.17725497 |
| 37 | otic vesicle formation (GO:0030916) | 3.16841888 |
| 38 | protein-lipid complex assembly (GO:0065005) | 3.16600194 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16436861 |
| 40 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.14823198 |
| 41 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.14321119 |
| 42 | plasma membrane repair (GO:0001778) | 3.13068775 |
| 43 | nephron tubule morphogenesis (GO:0072078) | 3.12564171 |
| 44 | nephron epithelium morphogenesis (GO:0072088) | 3.12564171 |
| 45 | locomotory exploration behavior (GO:0035641) | 3.10291306 |
| 46 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.09793687 |
| 47 | * regulation of cell communication by electrical coupling (GO:0010649) | 3.09160133 |
| 48 | cell communication involved in cardiac conduction (GO:0086065) | 3.08722512 |
| 49 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.07820327 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.06584838 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.05429631 |
| 52 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.02716360 |
| 53 | neuron cell-cell adhesion (GO:0007158) | 3.01902643 |
| 54 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01849677 |
| 55 | renal tubule morphogenesis (GO:0061333) | 3.01547378 |
| 56 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.00139940 |
| 57 | regulation of glucokinase activity (GO:0033131) | 2.97677174 |
| 58 | regulation of hexokinase activity (GO:1903299) | 2.97677174 |
| 59 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.96686089 |
| 60 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.95192543 |
| 61 | lactate metabolic process (GO:0006089) | 2.93666107 |
| 62 | regulation of membrane repolarization (GO:0060306) | 2.93558779 |
| 63 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.89044867 |
| 64 | membrane depolarization during action potential (GO:0086010) | 2.89011649 |
| 65 | cellular response to sterol (GO:0036315) | 2.88402954 |
| 66 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.87799066 |
| 67 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.87690810 |
| 68 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.87300812 |
| 69 | pericardium development (GO:0060039) | 2.84216021 |
| 70 | positive regulation of protein autophosphorylation (GO:0031954) | 2.83682856 |
| 71 | cellular ketone body metabolic process (GO:0046950) | 2.83354846 |
| 72 | cellular response to cholesterol (GO:0071397) | 2.82317186 |
| 73 | protein localization to synapse (GO:0035418) | 2.79717006 |
| 74 | cardiac myofibril assembly (GO:0055003) | 2.78183846 |
| 75 | cholesterol efflux (GO:0033344) | 2.77909631 |
| 76 | potassium ion import (GO:0010107) | 2.76741373 |
| 77 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.76196989 |
| 78 | regulation of synaptic vesicle transport (GO:1902803) | 2.76130631 |
| 79 | retinal cone cell development (GO:0046549) | 2.75742207 |
| 80 | striated muscle hypertrophy (GO:0014897) | 2.75370268 |
| 81 | embryonic digestive tract morphogenesis (GO:0048557) | 2.74926902 |
| 82 | regulation of axon guidance (GO:1902667) | 2.74821696 |
| 83 | response to redox state (GO:0051775) | 2.74702236 |
| 84 | somite rostral/caudal axis specification (GO:0032525) | 2.74600038 |
| 85 | auditory receptor cell differentiation (GO:0042491) | 2.74129450 |
| 86 | cardiac right ventricle morphogenesis (GO:0003215) | 2.74077295 |
| 87 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74060000 |
| 88 | * regulation of calcium ion transmembrane transport (GO:1903169) | 2.71580722 |
| 89 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.71580722 |
| 90 | positive regulation of actin filament depolymerization (GO:0030836) | 2.71064230 |
| 91 | * regulation of relaxation of muscle (GO:1901077) | 2.71042152 |
| 92 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.69979267 |
| 93 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.69913636 |
| 94 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.69525387 |
| 95 | proline transport (GO:0015824) | 2.68691755 |
| 96 | cardiac muscle contraction (GO:0060048) | 2.68514104 |
| 97 | anterior/posterior axis specification, embryo (GO:0008595) | 2.68247315 |
| 98 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.68082165 |
| 99 | presynaptic membrane assembly (GO:0097105) | 2.67925942 |
| 100 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.66436372 |
| 101 | positive regulation of cation channel activity (GO:2001259) | 2.66101845 |
| 102 | activation of protein kinase A activity (GO:0034199) | 2.65624999 |
| 103 | cilium morphogenesis (GO:0060271) | 2.65399353 |
| 104 | regulation of sulfur metabolic process (GO:0042762) | 2.64687725 |
| 105 | neurotransmitter secretion (GO:0007269) | 2.62779392 |
| 106 | cardiac muscle adaptation (GO:0014887) | 2.61400089 |
| 107 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.61400089 |
| 108 | muscle hypertrophy in response to stress (GO:0003299) | 2.61400089 |
| 109 | regulation of actin filament-based movement (GO:1903115) | 2.60665822 |
| 110 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.60413873 |
| 111 | membrane repolarization (GO:0086009) | 2.58872220 |
| 112 | positive regulation of potassium ion transport (GO:0043268) | 2.58546728 |
| 113 | female gonad development (GO:0008585) | 2.57805497 |
| 114 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.55817176 |
| 115 | zinc ion transport (GO:0006829) | 2.55423018 |
| 116 | limb bud formation (GO:0060174) | 2.54847965 |
| 117 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.54595018 |
| 118 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.54581483 |
| 119 | detection of calcium ion (GO:0005513) | 2.54490801 |
| 120 | * relaxation of cardiac muscle (GO:0055119) | 2.53386564 |
| 121 | membrane assembly (GO:0071709) | 2.53150419 |
| 122 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.52992939 |
| 123 | Golgi to endosome transport (GO:0006895) | 2.52955175 |
| 124 | * cardiac conduction (GO:0061337) | 2.52259612 |
| 125 | rhodopsin mediated signaling pathway (GO:0016056) | 2.51745573 |
| 126 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.51038573 |
| 127 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.50396536 |
| 128 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.50026722 |
| 129 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.49946064 |
| 130 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.49946064 |
| 131 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.49946064 |
| 132 | * positive regulation of muscle hypertrophy (GO:0014742) | 2.49691345 |
| 133 | * positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.49691345 |
| 134 | regulation of synapse structural plasticity (GO:0051823) | 2.49674402 |
| 135 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.49172138 |
| 136 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.48274460 |
| 137 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.47695011 |
| 138 | sarcomere organization (GO:0045214) | 2.47582634 |
| 139 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.46700471 |
| 140 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.46524504 |
| 141 | regulation of neurotransmitter secretion (GO:0046928) | 2.46368387 |
| 142 | regulation of sarcomere organization (GO:0060297) | 2.45948053 |
| 143 | ketone body metabolic process (GO:1902224) | 2.45806668 |
| 144 | cardiac muscle cell development (GO:0055013) | 2.43557369 |
| 145 | intracellular lipid transport (GO:0032365) | 2.43013124 |
| 146 | * regulation of cation channel activity (GO:2001257) | 2.42520617 |
| 147 | layer formation in cerebral cortex (GO:0021819) | 2.41068092 |
| 148 | * actin-mediated cell contraction (GO:0070252) | 2.40212656 |
| 149 | * regulation of cardiac muscle contraction (GO:0055117) | 2.39840550 |
| 150 | high-density lipoprotein particle remodeling (GO:0034375) | 2.39673791 |
| 151 | regulation of protein glycosylation (GO:0060049) | 2.38870578 |
| 152 | response to BMP (GO:0071772) | 2.38458887 |
| 153 | cellular response to BMP stimulus (GO:0071773) | 2.38458887 |
| 154 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.38408396 |
| 155 | membrane repolarization during action potential (GO:0086011) | 2.38358360 |
| 156 | potassium ion homeostasis (GO:0055075) | 2.38230833 |
| 157 | DNA integration (GO:0015074) | 2.38028352 |
| 158 | histamine secretion (GO:0001821) | 2.37165377 |
| 159 | C-terminal protein lipidation (GO:0006501) | 2.36626165 |
| 160 | establishment of nucleus localization (GO:0040023) | 2.36519662 |
| 161 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.34817661 |
| 162 | branched-chain amino acid catabolic process (GO:0009083) | 2.34734811 |
| 163 | * regulation of striated muscle contraction (GO:0006942) | 2.34455225 |
| 164 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.33779670 |
| 165 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.33541635 |
| 166 | regulation of postsynaptic membrane potential (GO:0060078) | 2.33522858 |
| 167 | vesicle transport along microtubule (GO:0047496) | 2.33405099 |
| 168 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.32991318 |
| 169 | embryonic epithelial tube formation (GO:0001838) | 2.32421818 |
| 170 | glutamate receptor signaling pathway (GO:0007215) | 2.32276848 |
| 171 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.31948812 |
| 172 | myofibril assembly (GO:0030239) | 2.31881852 |
| 173 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.31172065 |
| 174 | amino acid salvage (GO:0043102) | 2.31133630 |
| 175 | L-methionine salvage (GO:0071267) | 2.31133630 |
| 176 | L-methionine biosynthetic process (GO:0071265) | 2.31133630 |
| 177 | axoneme assembly (GO:0035082) | 2.30876347 |
| 178 | membrane depolarization (GO:0051899) | 2.29616551 |
| 179 | synaptic vesicle endocytosis (GO:0048488) | 2.29385814 |
| 180 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.29139272 |
| 181 | postsynaptic membrane organization (GO:0001941) | 2.28639953 |
| 182 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.27755516 |
| 183 | cardiac muscle hypertrophy (GO:0003300) | 2.26947263 |
| 184 | exploration behavior (GO:0035640) | 2.26543346 |
| 185 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.24242889 |
| 186 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.23608549 |
| 187 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.23608549 |
| 188 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.22990912 |
| 189 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.21262334 |
| 190 | photoreceptor cell development (GO:0042461) | 2.20958526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.00341853 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.07221043 |
| 3 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59932130 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39032314 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32012102 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17640566 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.09779701 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05310310 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.04192453 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.04192453 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03336639 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.02908587 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.99130920 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95671378 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91539341 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91001946 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.89597416 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86106151 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84152509 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.83686659 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80095246 |
| 22 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77194750 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.76542319 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75621154 |
| 25 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.73178777 |
| 26 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.70974375 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.69597376 |
| 28 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67226195 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.66375327 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64561950 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.64452919 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63067942 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62915390 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62842298 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61739690 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.60404833 |
| 37 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.57549860 |
| 38 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.55791190 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54769078 |
| 40 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53641117 |
| 41 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53431808 |
| 42 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.52532384 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.51781467 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51053279 |
| 45 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.49430703 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46783954 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46251996 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.45752592 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.44815951 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44476740 |
| 51 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44369644 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.43329364 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42893633 |
| 54 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42333984 |
| 55 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.42059580 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41080841 |
| 57 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.39662573 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37677701 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37647540 |
| 60 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37525951 |
| 61 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.37178390 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35704810 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.35658844 |
| 64 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33567228 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.33534430 |
| 66 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.32673344 |
| 67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.32229129 |
| 68 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.31516000 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31411737 |
| 70 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.31328367 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30602374 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30324933 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30324933 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.30300423 |
| 75 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29731780 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.29598246 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29332683 |
| 78 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29021188 |
| 79 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28840328 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27262178 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.26408927 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26270047 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26066218 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26066218 |
| 85 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.25710034 |
| 86 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25094502 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24602965 |
| 88 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24241287 |
| 89 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22970816 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22001475 |
| 91 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.21955090 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21696164 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20998774 |
| 94 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20009038 |
| 95 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.19827255 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19119674 |
| 97 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18866537 |
| 98 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.18494560 |
| 99 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18303708 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18301888 |
| 101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16379004 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15477443 |
| 103 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15245936 |
| 104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15211240 |
| 105 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14834548 |
| 106 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14114313 |
| 107 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.13691819 |
| 108 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.13056674 |
| 109 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.12670051 |
| 110 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11911052 |
| 111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11874047 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11119625 |
| 113 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10634283 |
| 114 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.10600694 |
| 115 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09240049 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08424561 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08081385 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08081385 |
| 119 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07977243 |
| 120 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07826515 |
| 121 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07770741 |
| 122 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07422518 |
| 123 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06964260 |
| 124 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05933513 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04537526 |
| 126 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04435047 |
| 127 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04271147 |
| 128 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03848739 |
| 129 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03059784 |
| 130 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02243223 |
| 131 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00570548 |
| 132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00418467 |
| 133 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00396726 |
| 134 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.99802685 |
| 135 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99674538 |
| 136 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99020396 |
| 137 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.98649294 |
| 138 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.98436743 |
| 139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97430948 |
| 140 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97350525 |
| 141 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95669159 |
| 142 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94365152 |
| 143 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92324531 |
| 144 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92280388 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90756021 |
| 146 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90426583 |
| 147 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88697133 |
| 148 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88440426 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87601339 |
| 150 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86240484 |
| 151 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85928081 |
| 152 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.85538662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 7.05018000 |
| 2 | MP0006054_spinal_hemorrhage | 4.24991189 |
| 3 | MP0000751_myopathy | 2.93338851 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 2.92340737 |
| 5 | MP0001968_abnormal_touch/_nociception | 2.82025728 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.81453291 |
| 7 | MP0001984_abnormal_olfaction | 2.55365360 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.53980795 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.47463342 |
| 10 | MP0009046_muscle_twitch | 2.36640514 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.32580815 |
| 12 | MP0004270_analgesia | 2.31575025 |
| 13 | MP0003646_muscle_fatigue | 2.31296144 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.30186953 |
| 15 | MP0004215_abnormal_myocardial_fiber | 2.29952279 |
| 16 | MP0002736_abnormal_nociception_after | 2.28043064 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.23854364 |
| 18 | MP0003880_abnormal_central_pattern | 2.21771877 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.20752221 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.17477114 |
| 21 | MP0004510_myositis | 2.12339415 |
| 22 | MP0000516_abnormal_urinary_system | 2.08055662 |
| 23 | MP0005367_renal/urinary_system_phenotyp | 2.08055662 |
| 24 | MP0008995_early_reproductive_senescence | 1.98733281 |
| 25 | MP0000569_abnormal_digit_pigmentation | 1.92710091 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.91109540 |
| 27 | MP0000749_muscle_degeneration | 1.88893100 |
| 28 | MP0009745_abnormal_behavioral_response | 1.87679634 |
| 29 | MP0002064_seizures | 1.82500774 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.80602274 |
| 31 | * MP0004484_altered_response_of | 1.74326117 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.69160923 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.68409505 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.68173935 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.65865440 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.65522351 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.64003566 |
| 38 | MP0004858_abnormal_nervous_system | 1.63668871 |
| 39 | MP0002272_abnormal_nervous_system | 1.61271320 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.59907690 |
| 41 | MP0002163_abnormal_gland_morphology | 1.59666489 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.57708317 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.56161390 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.54798981 |
| 45 | MP0003136_yellow_coat_color | 1.52822851 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.50917173 |
| 47 | MP0004085_abnormal_heartbeat | 1.50710937 |
| 48 | MP0003045_fibrosis | 1.50132067 |
| 49 | MP0001970_abnormal_pain_threshold | 1.49849889 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.49179876 |
| 51 | MP0008569_lethality_at_weaning | 1.49027132 |
| 52 | MP0003279_aneurysm | 1.47403711 |
| 53 | MP0001485_abnormal_pinna_reflex | 1.45393247 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.44271396 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.43649801 |
| 56 | MP0002102_abnormal_ear_morphology | 1.42135995 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.40910907 |
| 58 | MP0002938_white_spotting | 1.40718680 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.40075950 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.39637066 |
| 61 | MP0003941_abnormal_skin_development | 1.39601403 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.39254352 |
| 63 | MP0005623_abnormal_meninges_morphology | 1.37693490 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.36274701 |
| 65 | MP0004130_abnormal_muscle_cell | 1.34388608 |
| 66 | MP0002090_abnormal_vision | 1.34035104 |
| 67 | MP0001486_abnormal_startle_reflex | 1.33575883 |
| 68 | MP0008877_abnormal_DNA_methylation | 1.31472689 |
| 69 | MP0000639_abnormal_adrenal_gland | 1.30878463 |
| 70 | MP0004924_abnormal_behavior | 1.29773857 |
| 71 | MP0005386_behavior/neurological_phenoty | 1.29773857 |
| 72 | MP0002184_abnormal_innervation | 1.29659091 |
| 73 | MP0005330_cardiomyopathy | 1.27640935 |
| 74 | MP0004087_abnormal_muscle_fiber | 1.27479525 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 1.27434567 |
| 76 | MP0005253_abnormal_eye_physiology | 1.24238191 |
| 77 | MP0005187_abnormal_penis_morphology | 1.20448139 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.16066936 |
| 79 | MP0003137_abnormal_impulse_conducting | 1.15576690 |
| 80 | MP0003385_abnormal_body_wall | 1.15543756 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 1.13228407 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 1.10993941 |
| 83 | MP0000013_abnormal_adipose_tissue | 1.10183560 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 1.09577855 |
| 85 | MP0003937_abnormal_limbs/digits/tail_de | 1.09087339 |
| 86 | MP0001958_emphysema | 1.07782759 |
| 87 | MP0004133_heterotaxia | 1.07545396 |
| 88 | MP0005503_abnormal_tendon_morphology | 1.07426415 |
| 89 | MP0004233_abnormal_muscle_weight | 1.06905871 |
| 90 | MP0008004_abnormal_stomach_pH | 1.03683595 |
| 91 | MP0000427_abnormal_hair_cycle | 1.03657922 |
| 92 | MP0003828_pulmonary_edema | 1.02619722 |
| 93 | MP0004885_abnormal_endolymph | 1.01967919 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 1.01534965 |
| 95 | MP0005385_cardiovascular_system_phenoty | 1.01534965 |
| 96 | MP0010329_abnormal_lipoprotein_level | 1.01092579 |
| 97 | MP0002106_abnormal_muscle_physiology | 0.99626092 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 0.99412903 |
| 99 | MP0000747_muscle_weakness | 0.97584402 |
| 100 | MP0004811_abnormal_neuron_physiology | 0.97428706 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.97156649 |
| 102 | MP0003091_abnormal_cell_migration | 0.97143979 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.96928452 |
| 104 | MP0002557_abnormal_social/conspecific_i | 0.95594134 |
| 105 | MP0005275_abnormal_skin_tensile | 0.94618738 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.94183338 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.93231985 |
| 108 | MP0002882_abnormal_neuron_morphology | 0.92493426 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.92198915 |
| 110 | MP0003283_abnormal_digestive_organ | 0.92046253 |
| 111 | MP0003119_abnormal_digestive_system | 0.91017038 |
| 112 | MP0004019_abnormal_vitamin_homeostasis | 0.90728432 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.90616753 |
| 114 | MP0003633_abnormal_nervous_system | 0.90510522 |
| 115 | MP0002229_neurodegeneration | 0.88966732 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.88489176 |
| 117 | MP0005369_muscle_phenotype | 0.86947707 |
| 118 | MP0001756_abnormal_urination | 0.86721678 |
| 119 | MP0000759_abnormal_skeletal_muscle | 0.84907684 |
| 120 | MP0003787_abnormal_imprinting | 0.83893598 |
| 121 | MP0003122_maternal_imprinting | 0.82752780 |
| 122 | MP0006138_congestive_heart_failure | 0.82214159 |
| 123 | MP0002233_abnormal_nose_morphology | 0.81057029 |
| 124 | MP0003935_abnormal_craniofacial_develop | 0.80280433 |
| 125 | MP0003195_calcinosis | 0.79128449 |
| 126 | MP0000778_abnormal_nervous_system | 0.78360362 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.77697097 |
| 128 | MP0001188_hyperpigmentation | 0.76364682 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.74220351 |
| 130 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74036309 |
| 131 | MP0000604_amyloidosis | 0.73871506 |
| 132 | MP0002822_catalepsy | 0.73575055 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.72352115 |
| 134 | MP0002933_joint_inflammation | 0.72276530 |
| 135 | MP0005365_abnormal_bile_salt | 0.71600906 |
| 136 | MP0003121_genomic_imprinting | 0.69366681 |
| 137 | MP0002066_abnormal_motor_capabilities/c | 0.68511862 |
| 138 | MP0002108_abnormal_muscle_morphology | 0.68091667 |
| 139 | MP0004272_abnormal_basement_membrane | 0.67138425 |
| 140 | MP0005332_abnormal_amino_acid | 0.66903777 |
| 141 | MP0005195_abnormal_posterior_eye | 0.66767823 |
| 142 | MP0002139_abnormal_hepatobiliary_system | 0.66472832 |
| 143 | MP0002128_abnormal_blood_circulation | 0.64753583 |
| 144 | MP0004043_abnormal_pH_regulation | 0.64339491 |
| 145 | MP0003755_abnormal_palate_morphology | 0.63837692 |
| 146 | MP0000428_abnormal_craniofacial_morphol | 0.63417906 |
| 147 | MP0000534_abnormal_ureter_morphology | 0.63297196 |
| 148 | MP0000613_abnormal_salivary_gland | 0.63246327 |
| 149 | MP0000767_abnormal_smooth_muscle | 0.63057096 |
| 150 | MP0002168_other_aberrant_phenotype | 0.62814527 |
| 151 | MP0003786_premature_aging | 0.62662549 |
| 152 | MP0000647_abnormal_sebaceous_gland | 0.61942090 |
| 153 | MP0005174_abnormal_tail_pigmentation | 0.61328661 |
| 154 | MP0003943_abnormal_hepatobiliary_system | 0.61143987 |
| 155 | MP0002928_abnormal_bile_duct | 0.59796927 |
| 156 | MP0004264_abnormal_extraembryonic_tissu | 0.58414997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoalphalipoproteinemia (HP:0003233) | 5.50214219 |
| 2 | Facial diplegia (HP:0001349) | 4.21703204 |
| 3 | Congenital stationary night blindness (HP:0007642) | 3.95159306 |
| 4 | Congenital malformation of the right heart (HP:0011723) | 3.92060154 |
| 5 | Double outlet right ventricle (HP:0001719) | 3.92060154 |
| 6 | Intestinal atresia (HP:0011100) | 3.91019705 |
| 7 | Sudden death (HP:0001699) | 3.75328505 |
| 8 | Abnormal pancreas size (HP:0012094) | 3.60484209 |
| 9 | Hypolipoproteinemia (HP:0010981) | 3.58888035 |
| 10 | Atrial fibrillation (HP:0005110) | 3.52708311 |
| 11 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.50825522 |
| 12 | Febrile seizures (HP:0002373) | 3.49636012 |
| 13 | Central scotoma (HP:0000603) | 3.47724762 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 3.38167804 |
| 15 | Prolonged QT interval (HP:0001657) | 3.34295526 |
| 16 | Syncope (HP:0001279) | 3.30465299 |
| 17 | Short tibia (HP:0005736) | 3.27950977 |
| 18 | Supraventricular tachycardia (HP:0004755) | 3.16546495 |
| 19 | Focal seizures (HP:0007359) | 3.12046489 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 3.09566377 |
| 21 | Atonic seizures (HP:0010819) | 3.06882396 |
| 22 | Focal motor seizures (HP:0011153) | 3.05028508 |
| 23 | Vitreoretinal degeneration (HP:0000655) | 3.04688524 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.00994478 |
| 25 | Renal cortical cysts (HP:0000803) | 2.96089218 |
| 26 | Hypoplastic ischia (HP:0003175) | 2.88572277 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 2.83500962 |
| 28 | Abnormality of the ischium (HP:0003174) | 2.82248167 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.82059970 |
| 30 | Action tremor (HP:0002345) | 2.78345124 |
| 31 | Visual hallucinations (HP:0002367) | 2.77844536 |
| 32 | Abnormality of macular pigmentation (HP:0008002) | 2.76761453 |
| 33 | Bifid tongue (HP:0010297) | 2.75913185 |
| 34 | Bradycardia (HP:0001662) | 2.75725506 |
| 35 | Epileptic encephalopathy (HP:0200134) | 2.75662237 |
| 36 | Nephronophthisis (HP:0000090) | 2.72496055 |
| 37 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.68257110 |
| 38 | Calf muscle hypertrophy (HP:0008981) | 2.67880095 |
| 39 | Abnormal EKG (HP:0003115) | 2.65902505 |
| 40 | Scotoma (HP:0000575) | 2.64645505 |
| 41 | Ventricular fibrillation (HP:0001663) | 2.64104822 |
| 42 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.62943577 |
| 43 | Absent eyebrow (HP:0002223) | 2.59347203 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.57580107 |
| 45 | Proximal tubulopathy (HP:0000114) | 2.56159327 |
| 46 | Myotonia (HP:0002486) | 2.55712532 |
| 47 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.50343157 |
| 48 | Absence seizures (HP:0002121) | 2.44196376 |
| 49 | Absent frontal sinuses (HP:0002688) | 2.43810652 |
| 50 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.40740175 |
| 51 | Abnormality of midbrain morphology (HP:0002418) | 2.37099320 |
| 52 | Molar tooth sign on MRI (HP:0002419) | 2.37099320 |
| 53 | Epiphyseal dysplasia (HP:0002656) | 2.35530392 |
| 54 | Amelogenesis imperfecta (HP:0000705) | 2.34467352 |
| 55 | Areflexia of lower limbs (HP:0002522) | 2.33251324 |
| 56 | Hyperglycinemia (HP:0002154) | 2.27065288 |
| 57 | Hypoventilation (HP:0002791) | 2.25950310 |
| 58 | Pancreatic cysts (HP:0001737) | 2.25547744 |
| 59 | Dysmetric saccades (HP:0000641) | 2.24948225 |
| 60 | Exercise-induced muscle cramps (HP:0003710) | 2.22753614 |
| 61 | Bundle branch block (HP:0011710) | 2.21396233 |
| 62 | Pheochromocytoma (HP:0002666) | 2.20185322 |
| 63 | Ventricular arrhythmia (HP:0004308) | 2.20133009 |
| 64 | Lower limb amyotrophy (HP:0007210) | 2.18235384 |
| 65 | Vertebral arch anomaly (HP:0008438) | 2.18194933 |
| 66 | True hermaphroditism (HP:0010459) | 2.17431429 |
| 67 | Truncal ataxia (HP:0002078) | 2.16343125 |
| 68 | Cupped ribs (HP:0000887) | 2.15708462 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.15390302 |
| 70 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.14535668 |
| 71 | Genetic anticipation (HP:0003743) | 2.14316412 |
| 72 | Fragile skin (HP:0001030) | 2.13989632 |
| 73 | Myokymia (HP:0002411) | 2.13974978 |
| 74 | Dyschromatopsia (HP:0007641) | 2.13813562 |
| 75 | Large for gestational age (HP:0001520) | 2.11433966 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 2.09367822 |
| 77 | Dialeptic seizures (HP:0011146) | 2.08599780 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 2.07601188 |
| 79 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.06271299 |
| 80 | Transposition of the great arteries (HP:0001669) | 2.06271299 |
| 81 | Abnormal connection of the cardiac segments (HP:0011545) | 2.06271299 |
| 82 | Occipital encephalocele (HP:0002085) | 2.05508762 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.04956982 |
| 84 | Ectropion (HP:0000656) | 2.04627261 |
| 85 | Broad-based gait (HP:0002136) | 2.04535705 |
| 86 | Exercise-induced myalgia (HP:0003738) | 2.03445732 |
| 87 | Glycosuria (HP:0003076) | 2.00019911 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.00019911 |
| 89 | Abnormality of the renal cortex (HP:0011035) | 1.99559734 |
| 90 | EMG: myopathic abnormalities (HP:0003458) | 1.99469218 |
| 91 | Pancreatic fibrosis (HP:0100732) | 1.98600692 |
| 92 | Lipoatrophy (HP:0100578) | 1.97911056 |
| 93 | Aortic aneurysm (HP:0004942) | 1.97536042 |
| 94 | Genital tract atresia (HP:0001827) | 1.96517586 |
| 95 | Right ventricular cardiomyopathy (HP:0011663) | 1.96451650 |
| 96 | Neuroendocrine neoplasm (HP:0100634) | 1.95094001 |
| 97 | Hemiparesis (HP:0001269) | 1.94603705 |
| 98 | Distal lower limb amyotrophy (HP:0008944) | 1.94544520 |
| 99 | Medial flaring of the eyebrow (HP:0010747) | 1.94210205 |
| 100 | Anal stenosis (HP:0002025) | 1.92959744 |
| 101 | Vaginal atresia (HP:0000148) | 1.92854795 |
| 102 | Choroideremia (HP:0001139) | 1.92191110 |
| 103 | Popliteal pterygium (HP:0009756) | 1.90059841 |
| 104 | Ventricular tachycardia (HP:0004756) | 1.88835609 |
| 105 | Pigmentary retinal degeneration (HP:0001146) | 1.88191115 |
| 106 | Generalized tonic-clonic seizures (HP:0002069) | 1.87809234 |
| 107 | Chorioretinal atrophy (HP:0000533) | 1.87712994 |
| 108 | Nemaline bodies (HP:0003798) | 1.85320067 |
| 109 | Hyperventilation (HP:0002883) | 1.84830321 |
| 110 | Absent speech (HP:0001344) | 1.84784931 |
| 111 | Cerebellar dysplasia (HP:0007033) | 1.84455777 |
| 112 | Abnormality of the parathyroid morphology (HP:0011766) | 1.83749055 |
| 113 | Hypoglycemic coma (HP:0001325) | 1.82731540 |
| 114 | Preaxial foot polydactyly (HP:0001841) | 1.82465171 |
| 115 | Abnormality of alanine metabolism (HP:0010916) | 1.82249747 |
| 116 | Hyperalaninemia (HP:0003348) | 1.82249747 |
| 117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82249747 |
| 118 | Limited hip movement (HP:0008800) | 1.82141541 |
| 119 | Soft skin (HP:0000977) | 1.81569829 |
| 120 | Small hand (HP:0200055) | 1.79224792 |
| 121 | Hypothermia (HP:0002045) | 1.79043934 |
| 122 | Asymmetry of the thorax (HP:0001555) | 1.78252805 |
| 123 | Muscle fiber splitting (HP:0003555) | 1.78164186 |
| 124 | Hyperglycemia (HP:0003074) | 1.77247918 |
| 125 | Impaired pain sensation (HP:0007328) | 1.76856132 |
| 126 | Abnormality of pain sensation (HP:0010832) | 1.76856132 |
| 127 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.76589964 |
| 128 | Short chin (HP:0000331) | 1.76289791 |
| 129 | Increased connective tissue (HP:0009025) | 1.75695704 |
| 130 | Increased corneal curvature (HP:0100692) | 1.74278480 |
| 131 | Keratoconus (HP:0000563) | 1.74278480 |
| 132 | Increased CSF protein (HP:0002922) | 1.74106262 |
| 133 | Left ventricular hypertrophy (HP:0001712) | 1.73895979 |
| 134 | Hypercortisolism (HP:0001578) | 1.73088814 |
| 135 | Renal hypoplasia (HP:0000089) | 1.72490535 |
| 136 | Papilledema (HP:0001085) | 1.72105812 |
| 137 | Ulnar claw (HP:0001178) | 1.71946036 |
| 138 | Disproportionate short-trunk short stature (HP:0003521) | 1.71870018 |
| 139 | Palpitations (HP:0001962) | 1.71421309 |
| 140 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.71024213 |
| 141 | Flat acetabular roof (HP:0003180) | 1.70692327 |
| 142 | Stage 5 chronic kidney disease (HP:0003774) | 1.70386695 |
| 143 | Small epiphyses (HP:0010585) | 1.69855324 |
| 144 | Steppage gait (HP:0003376) | 1.69533912 |
| 145 | Vascular tortuosity (HP:0004948) | 1.69393741 |
| 146 | Preauricular pit (HP:0004467) | 1.69393264 |
| 147 | Periauricular skin pits (HP:0100277) | 1.69393264 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.69289888 |
| 149 | Narrow forehead (HP:0000341) | 1.68864548 |
| 150 | Muscle fiber inclusion bodies (HP:0100299) | 1.68691800 |
| 151 | Acute lymphatic leukemia (HP:0006721) | 1.68229616 |
| 152 | Delayed gross motor development (HP:0002194) | 1.68070360 |
| 153 | Postaxial foot polydactyly (HP:0001830) | 1.67729199 |
| 154 | Lower limb asymmetry (HP:0100559) | 1.67240662 |
| 155 | Prominent supraorbital ridges (HP:0000336) | 1.66996580 |
| 156 | Foot dorsiflexor weakness (HP:0009027) | 1.66554479 |
| 157 | Neonatal short-limb short stature (HP:0008921) | 1.66375802 |
| 158 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66324034 |
| 159 | Supranuclear gaze palsy (HP:0000605) | 1.65467734 |
| 160 | Gastrointestinal atresia (HP:0002589) | 1.64617877 |
| 161 | Pulmonic stenosis (HP:0001642) | 1.64184724 |
| 162 | Postaxial hand polydactyly (HP:0001162) | 1.64058667 |
| 163 | Dysdiadochokinesis (HP:0002075) | 1.63840133 |
| 164 | Volvulus (HP:0002580) | 1.62237473 |
| 165 | Concave nail (HP:0001598) | 1.61931355 |
| 166 | Abnormality of vitamin B metabolism (HP:0004340) | 1.61690787 |
| 167 | Irregular epiphyses (HP:0010582) | 1.61658610 |
| 168 | Methylmalonic acidemia (HP:0002912) | 1.61204795 |
| 169 | Abnormality of the frontal sinuses (HP:0002687) | 1.60907719 |
| 170 | Increased variability in muscle fiber diameter (HP:0003557) | 1.60699928 |
| 171 | Single umbilical artery (HP:0001195) | 1.60414253 |
| 172 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.60414253 |
| 173 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.60414253 |
| 174 | Arterial tortuosity (HP:0005116) | 1.59395765 |
| 175 | Macroorchidism (HP:0000053) | 1.59272100 |
| 176 | Oculomotor apraxia (HP:0000657) | 1.59009692 |
| 177 | Abnormality of the foot musculature (HP:0001436) | 1.56821099 |
| 178 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.56595524 |
| 179 | Abnormality of the pubic bones (HP:0003172) | 1.56553926 |
| 180 | Aqueductal stenosis (HP:0002410) | 1.55912886 |
| 181 | Lumbar hyperlordosis (HP:0002938) | 1.55274421 |
| 182 | Decreased central vision (HP:0007663) | 1.54804301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 7.00520561 |
| 2 | MAP4K2 | 3.76579466 |
| 3 | BCR | 3.45404744 |
| 4 | BRD4 | 2.45410002 |
| 5 | CASK | 2.34787578 |
| 6 | FRK | 2.31592168 |
| 7 | NTRK3 | 2.18966233 |
| 8 | LMTK2 | 2.17181445 |
| 9 | MAP3K4 | 2.16142979 |
| 10 | MINK1 | 2.07454727 |
| 11 | PHKG1 | 2.03294897 |
| 12 | PHKG2 | 2.03294897 |
| 13 | MAP3K12 | 1.98709106 |
| 14 | STK24 | 1.96311811 |
| 15 | OBSCN | 1.85634624 |
| 16 | RIPK4 | 1.81264638 |
| 17 | MYLK | 1.73174771 |
| 18 | MAP3K13 | 1.68201160 |
| 19 | PLK2 | 1.68026874 |
| 20 | WNK3 | 1.62464820 |
| 21 | MAP2K7 | 1.60963761 |
| 22 | CAMKK2 | 1.59683085 |
| 23 | PDK2 | 1.55128222 |
| 24 | SGK2 | 1.54339822 |
| 25 | STK39 | 1.53993517 |
| 26 | ERBB3 | 1.52239325 |
| 27 | TTN | 1.51568354 |
| 28 | SIK2 | 1.50252486 |
| 29 | NLK | 1.47086312 |
| 30 | MUSK | 1.45324104 |
| 31 | PIK3CA | 1.45222627 |
| 32 | MARK1 | 1.44700121 |
| 33 | ACVR1B | 1.44009887 |
| 34 | BMPR1B | 1.41697666 |
| 35 | STK3 | 1.40996338 |
| 36 | MAPK13 | 1.40991626 |
| 37 | MAP3K9 | 1.40244837 |
| 38 | SIK3 | 1.40114437 |
| 39 | PRKCH | 1.36041913 |
| 40 | RIPK1 | 1.33640965 |
| 41 | SGK3 | 1.30271874 |
| 42 | PRKD3 | 1.27763552 |
| 43 | PNCK | 1.26979777 |
| 44 | GRK5 | 1.25766531 |
| 45 | PAK3 | 1.24766903 |
| 46 | WNK1 | 1.23034092 |
| 47 | FGFR3 | 1.22835892 |
| 48 | DAPK2 | 1.21754877 |
| 49 | DMPK | 1.17589082 |
| 50 | CAMKK1 | 1.17369430 |
| 51 | MAPK12 | 1.17317139 |
| 52 | GRK7 | 1.16367134 |
| 53 | MAP2K4 | 1.15206781 |
| 54 | MST4 | 1.12215164 |
| 55 | CAMK1G | 1.07579996 |
| 56 | JAK1 | 1.05885634 |
| 57 | CDC42BPA | 1.05638758 |
| 58 | SGK494 | 1.03268112 |
| 59 | SGK223 | 1.03268112 |
| 60 | PAK6 | 1.01985699 |
| 61 | STK38L | 0.99611496 |
| 62 | NTRK1 | 0.98153493 |
| 63 | NTRK2 | 0.97821131 |
| 64 | ERBB4 | 0.97379207 |
| 65 | MST1R | 0.96099403 |
| 66 | ROCK1 | 0.94044980 |
| 67 | GRK1 | 0.93009950 |
| 68 | STK38 | 0.92091882 |
| 69 | EIF2AK3 | 0.89858568 |
| 70 | FER | 0.89082776 |
| 71 | LIMK1 | 0.89026946 |
| 72 | PBK | 0.88826154 |
| 73 | FES | 0.86651715 |
| 74 | CDK5 | 0.85343148 |
| 75 | RET | 0.83901817 |
| 76 | TRPM7 | 0.83103838 |
| 77 | PRKCE | 0.81674621 |
| 78 | MAP3K14 | 0.81633967 |
| 79 | CAMK2A | 0.79927002 |
| 80 | CAMK1 | 0.79817700 |
| 81 | TNIK | 0.77220523 |
| 82 | OXSR1 | 0.76867040 |
| 83 | MET | 0.76521101 |
| 84 | NUAK1 | 0.76517950 |
| 85 | * CAMK2D | 0.75467602 |
| 86 | STK16 | 0.75341732 |
| 87 | NEK1 | 0.73466787 |
| 88 | SGK1 | 0.72905846 |
| 89 | NEK9 | 0.71786808 |
| 90 | CAMK1D | 0.70964158 |
| 91 | TGFBR2 | 0.70773698 |
| 92 | MAP3K7 | 0.69887527 |
| 93 | PTK2B | 0.67587886 |
| 94 | KSR1 | 0.65978142 |
| 95 | WEE1 | 0.65801164 |
| 96 | PRKG2 | 0.65318233 |
| 97 | PIK3CG | 0.65205945 |
| 98 | RPS6KA2 | 0.63615716 |
| 99 | PDK1 | 0.62337472 |
| 100 | CAMK4 | 0.62126331 |
| 101 | PRPF4B | 0.61686823 |
| 102 | ROCK2 | 0.61126820 |
| 103 | MELK | 0.58814471 |
| 104 | MAPK7 | 0.58361598 |
| 105 | PRKCG | 0.58299946 |
| 106 | EPHA4 | 0.56323889 |
| 107 | ADRBK1 | 0.56044096 |
| 108 | DDR2 | 0.54691406 |
| 109 | FGFR1 | 0.53430824 |
| 110 | LATS1 | 0.53390635 |
| 111 | MAP3K2 | 0.52877827 |
| 112 | PINK1 | 0.52459097 |
| 113 | ZAK | 0.52295411 |
| 114 | FYN | 0.52258608 |
| 115 | WNK4 | 0.52253750 |
| 116 | TNK2 | 0.50117576 |
| 117 | MAP3K5 | 0.48983641 |
| 118 | STK11 | 0.47952764 |
| 119 | MAP2K1 | 0.47865542 |
| 120 | NEK2 | 0.47675806 |
| 121 | PLK3 | 0.47433647 |
| 122 | TIE1 | 0.46170705 |
| 123 | PRKD1 | 0.45939191 |
| 124 | KSR2 | 0.45521719 |
| 125 | MKNK2 | 0.42281923 |
| 126 | SYK | 0.41303224 |
| 127 | AKT3 | 0.41291186 |
| 128 | PKN2 | 0.41139593 |
| 129 | PRKG1 | 0.40608721 |
| 130 | DAPK3 | 0.39601329 |
| 131 | DYRK1A | 0.38877592 |
| 132 | SCYL2 | 0.38409441 |
| 133 | LATS2 | 0.38012499 |
| 134 | HIPK2 | 0.37338841 |
| 135 | FGFR2 | 0.37177598 |
| 136 | ADRBK2 | 0.33256580 |
| 137 | TGFBR1 | 0.31625913 |
| 138 | CSNK1G1 | 0.28676544 |
| 139 | CSNK1G2 | 0.26975016 |
| 140 | BCKDK | 0.26556787 |
| 141 | INSRR | 0.26497004 |
| 142 | EIF2AK2 | 0.26190182 |
| 143 | PRKACA | 0.25845506 |
| 144 | PKN1 | 0.25677517 |
| 145 | EGFR | 0.24403237 |
| 146 | STK4 | 0.22380684 |
| 147 | INSR | 0.20438357 |
| 148 | TAF1 | 0.15912219 |
| 149 | ABL1 | 0.15624207 |
| 150 | * PRKCB | 0.15494945 |
| 151 | PRKACB | 0.14401859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.13872347 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.01747436 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.00398431 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.91580754 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.85916471 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66135293 |
| 7 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.40371528 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.39941739 |
| 9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.29278482 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20807831 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16435686 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.15549622 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08177955 |
| 14 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.05023299 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.04490893 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.02314905 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.86970082 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.82695492 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.78146205 |
| 20 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.77251480 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.74584882 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69484177 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.68660155 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.68391855 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.63945682 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60524752 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.58345782 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55606976 |
| 29 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55255281 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54919907 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.46391766 |
| 32 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.44742139 |
| 33 | * Long-term potentiation_Homo sapiens_hsa04720 | 1.44263416 |
| 34 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40646622 |
| 35 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.40303071 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.38824990 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38691522 |
| 38 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.36916724 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.31756024 |
| 40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31434147 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30928025 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.30424021 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29210369 |
| 44 | * Insulin secretion_Homo sapiens_hsa04911 | 1.27082633 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24675826 |
| 46 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22023534 |
| 47 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21834500 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19320537 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19232019 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18658040 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18150680 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.17102888 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15823694 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13999428 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13847786 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12193440 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11237185 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.10718841 |
| 59 | * Amphetamine addiction_Homo sapiens_hsa05031 | 1.09180011 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.08570217 |
| 61 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.06461444 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 1.05309497 |
| 63 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03731857 |
| 64 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.03461164 |
| 65 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03455908 |
| 66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.02374971 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00250104 |
| 68 | Tight junction_Homo sapiens_hsa04530 | 0.98617199 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98222124 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.97773403 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96643559 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96446760 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93027674 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.92511433 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92254743 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.90597906 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.90231260 |
| 78 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90095099 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89413958 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88967689 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88871439 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87455144 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86604199 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83434642 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82601368 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82561296 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81536053 |
| 88 | Focal adhesion_Homo sapiens_hsa04510 | 0.80912544 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80640053 |
| 90 | * Glioma_Homo sapiens_hsa05214 | 0.80259852 |
| 91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80104952 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80077959 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78902149 |
| 94 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78659826 |
| 95 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.78164507 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76637812 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75995928 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.75255277 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74865542 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74262077 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73611737 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71688618 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71285055 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70489705 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.69032635 |
| 106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68577750 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68226158 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68068712 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67804246 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.67327321 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66961740 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66626174 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66514235 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66513491 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66178790 |
| 116 | Salmonella infection_Homo sapiens_hsa05132 | 0.65501779 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65034370 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64980768 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64263649 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.63859631 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.63766877 |
| 122 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63659591 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62639832 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62077221 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61700340 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60825112 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60243178 |
| 128 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60189509 |
| 129 | Lysine degradation_Homo sapiens_hsa00310 | 0.59757347 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59576341 |
| 131 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.59549845 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59410732 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58352624 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57821894 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57396871 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57183183 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57173644 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57038716 |
| 139 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56987163 |
| 140 | * Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55790303 |
| 141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55372549 |
| 142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54993425 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54988302 |
| 144 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54610169 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54585204 |
| 146 | * Melanogenesis_Homo sapiens_hsa04916 | 0.53628344 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52953455 |
| 148 | * Tuberculosis_Homo sapiens_hsa05152 | 0.52553628 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.51388346 |
| 150 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51079721 |
| 151 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.50869170 |
| 152 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50585548 |
| 153 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50576935 |
| 154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50334757 |
| 155 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50313370 |
| 156 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50205473 |
| 157 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49692167 |
| 158 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48611924 |
| 159 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48600920 |
| 160 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48598475 |
| 161 | Melanoma_Homo sapiens_hsa05218 | 0.48595672 |
| 162 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48536566 |
| 163 | RNA degradation_Homo sapiens_hsa03018 | 0.48305317 |
| 164 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48296371 |
| 165 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46831773 |

